A basic treatment for leukemia For patients with acute myeloid leukemia, hematopoietic stem cell transplant offers a chance of curing the underlying cancer, in part
EDITOR’S CHOICE IN DISEASE & MEDICINE The paper A.L. Boyd et al., “Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence,”
Hotspot mutations in isocitrate dehydrogenase 1 ( IDH1) and isocitrate dehydrogenase 2 ( IDH2) occur in a variety of myeloid malignancies and solid tumors. Mutant
Researchers have halted the progression of leukemia in mice by restoring the enzyme TET2 in hematopoietic stem cells, either by reestablishing its gene expression in
Created by ePubSystems. Contact Us for similar site for your university or institute.